Épisode maniaque induit par la Bromocriptine en post-partum

Misdrahi, D.; Chalard, R; Verdoux, Hélène

doi:10.1016/s0368-2315(06)76376-1

Cited by 11 publications

(3 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Since then, 14 postpartum episodes have been reported, associated with its use (Brook and Cookson 1978; Vlissides et al 1978; Charbonnier and Planche 1981; Canterbury et al 1987; Kemperman and Zwanikken 1987; Daw 1988; Iffy et al 1989; Durst et al 1990; Fisher et al 1991; Reeves and Pinkofsky 1997; Pinardo Zabala et al 2003; Misdrahi et al 2006). In a fifteenth (Lake et al 1987), the mother became overactive before bromocriptine was prescribed.…”

Section: Bromocriptinementioning

confidence: 99%

“…Two mothers recovered after withdrawal of bromocriptine without other treatment (Charbonnier and Planche 1981; Canterbury et al 1987); but other episodes have lasted up to 2 months, and required much treatment, in one case ECT. Two mothers suffered previous manic episodes, including steroid-triggered episodes (Fisher et al 1991; Misdrahi et al 2006). One had a family history of psychosis (Fisher et al 1991).…”

Section: Bromocriptinementioning

confidence: 99%

See 1 more Smart Citation

Non-reproductive triggers of postpartum psychosis

Brockington

2016

Arch Womens Ment Health

View full text Add to dashboard Cite

Bipolar disorders, and other psychoses, are known to be triggered by a number of agents apart from the reproductive process. In some women, pregnant or recently delivered, psychosis may be due to these alternative triggers. There are substantial numbers of mothers suffering from childbearing psychoses, who have been prescribed bromocriptine or steroids, have had surgical operations or developed thyrotoxicosis. It is best to eliminate these episodes and cases from study samples of puerperal psychosis.

show abstract

Section: Bromocriptinementioning

confidence: 99%

Section: Bromocriptinementioning

confidence: 99%

Non-reproductive triggers of postpartum psychosis

Brockington

2016

Arch Womens Ment Health

View full text Add to dashboard Cite

show abstract

“…20,24 Twelve cases of acute psychiatric ADRs possibly related to lactation inhibition with bromocriptine were also found in the literature, with six cases of mania and six of postpartum psychosis. [55][56][57][58][59][60][61][62][63][64] Bromocriptine acting as a dopamine D2 agonist and a dopamine D1 partial agonist lends support to its implication in psychiatric disorders.…”

Section: Discussionmentioning

confidence: 99%

Severe adverse effects of bromocriptine in lactation inhibition: a pharmacovigilance survey

Bernard

Jantzem

Becker³

et al. 2015

BJOG

View full text Add to dashboard Cite

Objective To assess the nature and conditions of the occurrence of adverse drug reactions (ADRs) of bromocriptine, which is used to inhibit lactation.Design Observational study.Setting Cases from the French pharmacovigilance database and the marketing authorisation holders.Sample Serious ADRs reported between 1994 and 2010 in association with bromocriptine used for lactation inhibition in France.Methods Each case was checked to confirm the bromocriptine indication, the seriousness of the ADR, the modalities of bromocriptine use, and to identify possible associated predisposing factors.Main outcome measures Number and description of serious ADRs, with a particular focus on misuse and associated predisposing factors.Results Among 105 serious ADRs, including two fatal cases, the most frequent were cardiovascular (70.5%), neurological (14.3%), and psychiatric (8.6%) disorders. Cardiovascular disorders primarily consisted of ischaemic manifestations (n = 47): acute ischaemic stroke (n = 18, one death), myocardial infarction (n = 11, one death), and reversible postpartum cerebral angiopathy (n = 10). Misuse was identified in 52 cases (70.3%) of cardiovascular disorders, and mostly consisted of bromocriptine continuation despite the occurrence of first symptoms suggesting an ADR or the absence of a progressive titration of bromocriptine. About half of these women had cardiovascular predisposing factors, mainly tobacco smoking, overweight or obesity, or a history of hypertension or preeclampsia.Conclusions This survey, together with published data, provides further evidence that serious ADRs still occur after bromocriptine use in lactation inhibition, and that most of these ADRs could have been avoided. The use of bromocriptine should therefore be limited to cases where no other options are available to inhibit lactation.

show abstract

Psychotropic Drugs and the Perinatal Period

Sutter-Dallay

Riecher‐Rössler

2016

Joint Care of Parents and Infants in Perinatal Psychiatry

View full text Add to dashboard Cite

Épisode maniaque induit par la Bromocriptine en post-partum

Cited by 11 publications

References 7 publications

Non-reproductive triggers of postpartum psychosis

Non-reproductive triggers of postpartum psychosis

Severe adverse effects of bromocriptine in lactation inhibition: a pharmacovigilance survey

Psychotropic Drugs and the Perinatal Period

Contact Info

Product

Resources

About